Survival Benefit of Adjuvant Chemotherapy in Resected Squamous Carcinoma of the Gallbladder

被引：0
|
作者：
Olecki, Elizabeth [1 ]
Brahmbhatt, Rushin [1 ]
Peng, June [2 ]
Vining, Charles [1 ]
机构：
[1] Hershey Med Ctr, Hershey, PA USA
[2] Penn State Hershey Med Ctr, Hershey, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2024年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E258
引用
收藏
页码：S192 / S192
页数：1
相关论文
共 50 条
  • [31] IS ADJUVANT CHEMOTHERAPY ASSOCIATED WITH A SURVIVAL BENEFIT FOR PATIENTS WITH STAGE I MUCINOUS OVARIAN CARCINOMA?
    Nasioudis, D.
    Haggerty, A.
    Giuntoli, R., II
    Burger, R.
    Morgan, M.
    Ko, E.
    Latif, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 47 - 47
  • [32] Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis
    Byoung Hyuck Kim
    Jeanny Kwon
    Eui Kyu Chie
    Kyubo Kim
    Young Hoon Kim
    Dong Wan Seo
    Amol K. Narang
    Joseph M. Herman
    Annals of Surgical Oncology, 2018, 25 : 255 - 264
  • [33] Adjuvant chemotherapy is not associated with a survival benefit for patients with early stage mucinous ovarian carcinoma
    Nasioudis, Dimitrios
    Haggerty, Ashley F.
    Giuntoli, Robert L., II
    Burger, Robert A.
    Morgan, Mark A.
    Ito, Emily M.
    Latif, Nawar A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 (02) : 302 - 307
  • [34] ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer
    Turner, Kevin M.
    Patel, Sameer H.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4620 - 4621
  • [35] Adjuvant Chemoradiotherapy is Associated with Improved Survival for Patients with Resected Gallbladder Carcinoma: A Systematic Review and Meta-analysis
    Kim, Byoung Hyuck
    Kwon, Jeanny
    Chie, Eui Kyu
    Kim, Kyubo
    Kim, Young Hoon
    Seo, Dong Wan
    Narang, Amol K.
    Herman, Joseph M.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (01) : 255 - 264
  • [36] ASO Author Reflections: The Survival Advantage Persists: Benefit of Adjuvant Chemotherapy in Resected, Stage IA Pancreatic Cancer
    Kevin M. Turner
    Sameer H. Patel
    Annals of Surgical Oncology, 2022, 29 : 4620 - 4621
  • [37] NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma
    Cescon, David W.
    She, Desmond
    Sakashita, Shingo
    Zhu, Chang-Qi
    Pintilie, Melania
    Shepherd, Frances A.
    Tsao, Ming-Sound
    CLINICAL CANCER RESEARCH, 2015, 21 (11) : 2499 - 2505
  • [38] Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
    Mingqiu Chen
    Minmin Shen
    Yu Lin
    Pingping Liu
    Xiaohong Liu
    Xiqing Li
    Anchuan Li
    Rongqiang Yang
    Wei Ni
    Xin Zhou
    Lurong Zhang
    Benhua Xu
    Jianhua Lin
    Junqiang Chen
    Ye Tian
    Radiation Oncology, 13
  • [39] Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer
    Erin K. Greenleaf
    Afif N. Kulaylat
    Christopher S. Hollenbeak
    Khaldoun Almhanna
    Joyce Wong
    Annals of Surgical Oncology, 2016, 23 : 4203 - 4213
  • [40] Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
    Chen, Mingqiu
    Shen, Minmin
    Lin, Yu
    Liu, Pingping
    Liu, Xiaohong
    Li, Xiqing
    Li, Anchuan
    Yang, Rongqiang
    Ni, Wei
    Zhou, Xin
    Zhang, Lurong
    Xu, Benhua
    Lin, Jianhua
    Chen, Junqiang
    Tian, Ye
    RADIATION ONCOLOGY, 2018, 13
12345